Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free RKDA Stock Alerts

Arcadia Biosciences (RKDA) Competitors

Arcadia Biosciences logo
$1.07 +0.01 (+0.94%)
As of 04:00 PM Eastern
Compare

RKDA vs. NCRA, CEAD, IVP, ORIS, and EDBL

Should you buy Arcadia Biosciences stock or one of its competitors? MarketBeat compares Arcadia Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Arcadia Biosciences include Nocera (NCRA), CEA Industries (CEAD), Inspire Veterinary Partners (IVP), Oriental Rise (ORIS), and Edible Garden (EDBL). These companies are all part of the "agriculture" industry.

How does Arcadia Biosciences compare to Nocera?

Arcadia Biosciences (NASDAQ:RKDA) and Nocera (NASDAQ:NCRA) are both small-cap agriculture companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

In the previous week, Arcadia Biosciences and Arcadia Biosciences both had 3 articles in the media. Nocera's average media sentiment score of 1.43 beat Arcadia Biosciences' score of 0.43 indicating that Nocera is being referred to more favorably in the news media.

Company Overall Sentiment
Arcadia Biosciences Neutral
Nocera Positive

17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 1.3% of Nocera shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by company insiders. Comparatively, 5.2% of Nocera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Nocera has a net margin of -25.72% compared to Arcadia Biosciences' net margin of -48.15%. Arcadia Biosciences' return on equity of 37.36% beat Nocera's return on equity.

Company Net Margins Return on Equity Return on Assets
Arcadia Biosciences-48.15% 37.36% 23.95%
Nocera -25.72%-80.68%-39.27%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arcadia Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nocera
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Arcadia Biosciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Nocera has a beta of 1.72, meaning that its stock price is 72% more volatile than the broader market.

Arcadia Biosciences has higher earnings, but lower revenue than Nocera. Nocera is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arcadia Biosciences$4.86M0.45-$2.34M-$1.72N/A
Nocera$13.63M0.26-$2.84M-$0.24N/A

Summary

Arcadia Biosciences beats Nocera on 6 of the 11 factors compared between the two stocks.

How does Arcadia Biosciences compare to CEA Industries?

Arcadia Biosciences (NASDAQ:RKDA) and CEA Industries (NASDAQ:CEAD) are both small-cap agriculture companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

Arcadia Biosciences has a net margin of -48.15% compared to CEA Industries' net margin of -118.08%. Arcadia Biosciences' return on equity of 37.36% beat CEA Industries' return on equity.

Company Net Margins Return on Equity Return on Assets
Arcadia Biosciences-48.15% 37.36% 23.95%
CEA Industries -118.08%-27.79%-24.75%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arcadia Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CEA Industries
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 21.6% of CEA Industries shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by company insiders. Comparatively, 4.8% of CEA Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Arcadia Biosciences has higher revenue and earnings than CEA Industries. CEA Industries is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arcadia Biosciences$4.86M0.45-$2.34M-$1.72N/A
CEA Industries$3.28M0.75-$2.91M-$4.23N/A

In the previous week, Arcadia Biosciences had 3 more articles in the media than CEA Industries. MarketBeat recorded 3 mentions for Arcadia Biosciences and 0 mentions for CEA Industries. CEA Industries' average media sentiment score of 0.67 beat Arcadia Biosciences' score of 0.43 indicating that CEA Industries is being referred to more favorably in the news media.

Company Overall Sentiment
Arcadia Biosciences Neutral
CEA Industries Positive

Arcadia Biosciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, CEA Industries has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

Summary

Arcadia Biosciences beats CEA Industries on 10 of the 14 factors compared between the two stocks.

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Inspire Veterinary Partners (NASDAQ:IVP) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap agriculture companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Arcadia Biosciences has a net margin of -48.15% compared to Inspire Veterinary Partners' net margin of -76.75%. Arcadia Biosciences' return on equity of 37.36% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Veterinary Partners-76.75% -520.34% -55.79%
Arcadia Biosciences -48.15%37.36%23.95%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Arcadia Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

4.8% of Inspire Veterinary Partners shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 6.4% of Inspire Veterinary Partners shares are owned by insiders. Comparatively, 8.2% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Arcadia Biosciences has lower revenue, but higher earnings than Inspire Veterinary Partners. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Inspire Veterinary Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A
Arcadia Biosciences$4.86M0.45-$2.34M-$1.72N/A

In the previous week, Arcadia Biosciences had 3 more articles in the media than Inspire Veterinary Partners. MarketBeat recorded 3 mentions for Arcadia Biosciences and 0 mentions for Inspire Veterinary Partners. Arcadia Biosciences' average media sentiment score of 0.43 beat Inspire Veterinary Partners' score of 0.00 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Inspire Veterinary Partners Neutral
Arcadia Biosciences Neutral

Inspire Veterinary Partners has a beta of -0.49, meaning that its stock price is 149% less volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Summary

Arcadia Biosciences beats Inspire Veterinary Partners on 12 of the 13 factors compared between the two stocks.

How does Arcadia Biosciences compare to Oriental Rise?

Oriental Rise (NASDAQ:ORIS) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap agriculture companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Arcadia Biosciences had 2 more articles in the media than Oriental Rise. MarketBeat recorded 3 mentions for Arcadia Biosciences and 1 mentions for Oriental Rise. Oriental Rise's average media sentiment score of 1.87 beat Arcadia Biosciences' score of 0.43 indicating that Oriental Rise is being referred to more favorably in the media.

Company Overall Sentiment
Oriental Rise Very Positive
Arcadia Biosciences Neutral

Oriental Rise has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -48.15%. Arcadia Biosciences' return on equity of 37.36% beat Oriental Rise's return on equity.

Company Net Margins Return on Equity Return on Assets
Oriental RiseN/A N/A N/A
Arcadia Biosciences -48.15%37.36%23.95%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oriental Rise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Arcadia Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Oriental Rise has higher revenue and earnings than Arcadia Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oriental Rise$12.22M0.05$680KN/AN/A
Arcadia Biosciences$4.86M0.45-$2.34M-$1.72N/A

17.7% of Arcadia Biosciences shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Oriental Rise has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Summary

Arcadia Biosciences beats Oriental Rise on 6 of the 11 factors compared between the two stocks.

How does Arcadia Biosciences compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap agriculture companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Edible Garden had 1 more articles in the media than Arcadia Biosciences. MarketBeat recorded 4 mentions for Edible Garden and 3 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.43 beat Edible Garden's score of 0.36 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Edible Garden Neutral
Arcadia Biosciences Neutral

Arcadia Biosciences has a net margin of -48.15% compared to Edible Garden's net margin of -135.30%. Arcadia Biosciences' return on equity of 37.36% beat Edible Garden's return on equity.

Company Net Margins Return on Equity Return on Assets
Edible Garden-135.30% -1,078.80% -97.54%
Arcadia Biosciences -48.15%37.36%23.95%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edible Garden
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Arcadia Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Arcadia Biosciences has lower revenue, but higher earnings than Edible Garden. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Edible Garden, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edible Garden$12.81M0.03-$17.33M-$129.11N/A
Arcadia Biosciences$4.86M0.45-$2.34M-$1.72N/A

13.0% of Edible Garden shares are held by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are held by institutional investors. 0.1% of Edible Garden shares are held by insiders. Comparatively, 8.2% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Edible Garden has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Summary

Arcadia Biosciences beats Edible Garden on 9 of the 12 factors compared between the two stocks.

Get Arcadia Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RKDA vs. The Competition

Export
MetricArcadia BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.18M$3.40B$6.29B$12.40B
Dividend YieldN/A2.31%2.79%5.30%
P/E Ratio0.6818.9820.8925.59
Price / Sales0.45179.69523.4363.12
Price / Cash0.82122.5142.9455.34
Price / Book0.456.749.866.70
Net Income-$2.34M$24.11M$3.55B$333.77M
7 Day Performance-2.73%0.08%-0.33%0.45%
1 Month Performance-19.55%0.84%1.34%4.06%
1 Year Performance-74.28%78.10%41.10%36.24%

Arcadia Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RKDA
Arcadia Biosciences
0.6439 of 5 stars		$1.07
+0.9%		N/A-74.3%$2.18M$4.86M0.6860
NCRA
Nocera
0.7368 of 5 stars		$0.19
-6.4%		N/A-80.7%$3.18M$13.63MN/A10
CEAD
CEA Industries
N/A$3.19
-0.9%		N/A-55.8%$2.56M$3.28MN/A30
IVP
Inspire Veterinary Partners
0.0458 of 5 stars		$0.03
flat		N/AN/A$1.41M$15.56MN/A156
ORIS
Oriental Rise
0.5836 of 5 stars		$0.38
-4.6%		N/A-98.4%$417K$12.22MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RKDA) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
What Expenses Can Be Deducted From Capital Gains Tax This Year?
Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...
SmartAsset | Sponsoredtc pixel
One coin wired into Elon's vision
The SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...
Crypto 101 Media | Sponsoredtc pixel
Distracted Americans set to miss out on quadrillions
Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...
Brownstone Research | Sponsoredtc pixel